Rohto Pharmaceutical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: FMCG
  • ISIN: JP3982400008
JPY
2,862.50
500 (21.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
91,624.00
90,654.00
88,814.00
82,293.00
81,964.00
82,730.00
86,813.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
91,624.00
90,654.00
88,814.00
82,293.00
81,964.00
82,730.00
86,813.00
Raw Material Cost
40,575.00
40,806.00
38,192.00
37,463.00
36,617.00
37,473.00
36,984.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
320.00
371.00
311.00
286.00
316.00
385.00
436.00
Selling and Distribution Expenses
34,020.00
38,304.00
33,469.00
33,973.00
30,334.00
35,469.00
31,946.00
Other Expenses
304.50
370.10
273.70
306.90
307.00
285.40
309.40
Total Expenditure (Excl Depreciation)
77,960.00
83,182.00
74,709.00
74,791.00
70,337.00
76,181.00
72,460.00
Operating Profit (PBDIT) excl Other Income
13664
7472
14105
7502
11627
6549
14353
Other Income
1,553.00
1,152.00
1,451.00
1,263.00
4,821.00
2,590.00
2,351.00
Operating Profit (PBDIT)
19,712.00
13,292.00
20,188.00
12,757.00
20,533.00
13,784.00
20,757.00
Interest
320.00
371.00
311.00
286.00
316.00
385.00
436.00
Exceptional Items
-93.00
-196.00
-24.00
-9.00
-1,058.00
-1,218.00
-49.00
Gross Profit (PBDT)
51,049.00
49,848.00
50,622.00
44,830.00
45,347.00
45,257.00
49,829.00
Depreciation
4,495.00
4,668.00
4,632.00
3,992.00
4,085.00
4,645.00
4,053.00
Profit Before Tax
14,803.00
8,056.00
15,219.00
8,472.00
15,074.00
7,536.00
16,219.00
Tax
3,754.00
1,980.00
4,650.00
2,753.00
3,021.00
1,196.00
4,417.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
10,651.00
5,969.00
10,626.00
5,884.00
11,769.00
6,200.00
11,885.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
10,651.00
5,969.00
10,626.00
5,884.00
11,769.00
6,200.00
11,885.00
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
397.00
107.00
-57.00
-164.00
283.00
140.00
-83.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
11,048.00
6,076.00
10,569.00
5,720.00
12,052.00
6,340.00
11,802.00
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
3,09,489.00
3,01,828.00
2,87,458.00
2,75,188.00
2,66,743.00
2,60,095.00
2,56,071.00
Earnings per share (EPS)
46.5
24.17
44.8
24.93
51.39
27.02
51.95
Diluted Earnings per share
46.5
24.17
44.8
24.93
51.39
27.02
51.95
Operating Profit Margin (Excl OI)
14.91%
8.24%
15.88%
9.12%
14.19%
7.92%
16.53%
Gross Profit Margin
21.06%
14.04%
22.35%
15.15%
23.37%
14.72%
23.35%
PAT Margin
11.62%
6.58%
11.96%
7.15%
14.36%
7.49%
13.69%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 1.07% vs 2.07% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 81.83% vs -42.51% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 49.58% vs -35.21% in Mar 2026

stock-summary

Interest

QoQ Growth in quarter ended Jun 2026 is -13.75% vs 19.29% in Mar 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Rohto Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Net Sales
91,624.00
2,67,007.00
-1,75,383.00
-65.68%
Other Operating Income
0.00
0.00
0.00
Total Operating income
91,624.00
2,67,007.00
-1,75,383.00
-65.68%
Raw Material Cost
40,575.00
55,973.00
-15,398.00
-27.51%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
320.00
1,579.00
-1,259.00
-79.73%
Selling and Distribution Expenses
34,020.00
1,84,972.00
-1,50,952.00
-81.61%
Other Expenses
304.50
-157.90
462.40
292.84%
Total Expenditure (Excl Depreciation)
77,960.00
2,40,945.00
-1,62,985.00
-67.64%
Operating Profit (PBDIT) excl Other Income
13,664.00
26,062.00
-12,398.00
-47.57%
Other Income
1,553.00
6,273.00
-4,720.00
-75.24%
Operating Profit (PBDIT)
19,712.00
50,691.00
-30,979.00
-61.11%
Interest
320.00
1,579.00
-1,259.00
-79.73%
Exceptional Items
-93.00
0.00
-93.00
Gross Profit (PBDT)
51,049.00
2,11,034.00
-1,59,985.00
-75.81%
Depreciation
4,495.00
18,356.00
-13,861.00
-75.51%
Profit Before Tax
14,803.00
30,754.00
-15,951.00
-51.87%
Tax
3,754.00
10,270.00
-6,516.00
-63.45%
Provisions and contingencies
0
0
0.00
Profit After Tax
10,651.00
21,327.00
-10,676.00
-50.06%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
10,651.00
21,327.00
-10,676.00
-50.06%
Share in Profit of Associates
0
0
0.00
Minority Interest
397.00
-666.00
1,063.00
159.61%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
11,048.00
20,661.00
-9,613.00
-46.53%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
3,09,489.00
6,36,618.00
-3,27,129.00
-51.39%
Earnings per share (EPS)
46.50
53.36
-6.86
-12.86%
Diluted Earnings per share
46.50
53.36
-6.86
-12.86%
Operating Profit Margin (Excl OI)
14.91%
9.76%
0.00
5.15%
Gross Profit Margin
21.06%
18.39%
0.00
2.67%
PAT Margin
11.62%
7.99%
0.00
3.63%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 9,162.40 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 1.07% vs 2.07% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 11.79% vs 19.91% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 1,104.80 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 81.83% vs -42.51% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -8.33% vs 42.06% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,815.90 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 49.58% vs -35.21% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.57% vs 13.26% in Jun 2025

Quarterly - Interest
Interest 32.00 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -13.75% vs 19.29% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 1.27% vs 386.15% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 14.91%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025